-
Jan 14, 2025 | 
healio.com | David Statman |Mindy Valcarcel
Read more You've successfully added Hematology to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Jan 14, 2025 | 
healio.com | David Statman |Mindy Valcarcel
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In this video, Iberia Romina Sosa, MD, PhD, discusses the results of a study presented at ASH Annual Meeting and Exposition, which examined the risk of thrombosis in patients with a protein S deficiency.
-
Dec 27, 2024 | 
healio.com | David Statman
December 27, 2024 2 min watch VIDEO: Study examines FLT-3 inhibitors in leukemia treatment Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Leukemia. Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Dec 27, 2024 | 
healio.com | David Statman
Source: Healio Interviews Disclosures: Lai reports serving on an advisory board for Astellas, BMS, Daiichi, Genentech and Servier, consulting for AbbVie and Rigel, and receiving research funding from BMS and Jazz.
-
Dec 27, 2024 | 
healio.com | David Statman
You've successfully added Leukemia to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Dec 24, 2024 | 
healio.com | David Statman
December 24, 2024 5 min watch VIDEO: Bruton tyrosine kinase inhibitor studied in immune thrombocytopenia Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Dec 23, 2024 | 
healio.com | David Statman
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. In this video, Daniel DeAngelo, MD, PhD, discusses the results of a study presented at ASH Annual Meeting 2024 that examined the use of menin inhibitors in patients with leukemia.
-
Oct 30, 2024 | 
healio.com | David Statman |Mindy Valcarcel |Katharine Schulz-Costello
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. For many oncologists, the use of mastectomy to treat breast cancer cases can be a difficult subject to approach with patients.
-
Oct 21, 2024 | 
healio.com | David Statman |Mindy Valcarcel
October 21, 2024 3 min watch VIDEO: Timdarpacept ‘might have legs’ in chronic myelomonocytic leukemia treatment Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Leukemia. Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Oct 21, 2024 | 
healio.com | David Statman |Mindy Valcarcel
VIDEO: Dose expansion study performed on novel BCL-2 inhibitor for acute myeloid leukemiaIn this video, Noah Merin, MD, PhD, discusses the results of a Chinese study into the use of venetoclax in the treatment of acute myeloid leukemia and non-Hodgkin lymphoma, presented at ESMO Congress. Merin, director of the leukemia program at Cedars-Sinai Medical Center, highlighted the study, which was a dose escalation expansion study of a class of drug that AML has already displayed responsiveness to.
